Report Highlights
The global market for industrial enzymes was worth nearly $4.5 billion in 2012 and nearly $4.8 billion in 2013. The market is expected to reach around $7.1 billion by 2018, a compound annual growth rate (CAGR) of 8.2% from 2013 to 2018.
Report Includes
- An overview of the global market for enzymes used in industrial applications.
- Analyses of global market trends, with data from 2011 to 2013, and projections of CAGRs through 2018.
- Analysis of factors affecting the market such as the regulatory environment, growth drivers, needs of the market, and influencing technologies.
- Discussion of merger, acquisition, and collaboration strategies as well as discussion on the competitive landscape and structure of the industry.
- Comprehensive profiles of leading companies in the industry.
Report Scope
The scope of this study encompasses industrial enzymes in various industry sectors. BCC Research analyzes each market and its applications, regulatory environments, technology, market projections and market shares. Technological issues include the latest trends and developments.
Analyst Credentials
Shalini Shahani Dewan focuses on pharmaceuticals and biotechnology and has been a BCC Research contributor since 2002 as both an analyst and project manager. She has explored a wide range of topics and companies, including working for Johnson & Johnson doing market surveillance. She has an undergraduate degree in pharmacy and master's degree in medicinal chemistry. She resides in the Bay Area.
Report Highlights
The global market for industrial enzymes was valued at $3.1 billion in 2009 and reached about $3.6 billion in 2010. The estimated market for 2011 is about $3.9 billion. BCC projects this market to grow at a compounded annual growth rate (CAGR) of 9.1% to reach $6 billion by 2016.
Report Highlights
The global market for industrial enzymes is estimated at $3.3 billion in 2010. This market is expected to reach $4.4 billion by 2015, a compound annual growth rate (CAGR) of 6% over the 5-year forecast period.
Report Highlights
This Report:
- The global market for industrial enzymes increased from $2.2 billion in 2006 to an estimated $2.3 billion by the end of 2007. It should reach $2.7 billion by 2012, a compound annual growth rate (CAGR) of 4%.
- The greatest growth rate is expected in the animal enzymes sector, with a CAGR of 6% between 2007 and 2012, helped in large part by the increased use of phytase enzymes to fight phosphate pollution.
- New and emerging applications have helped drive demand for enzymes, and the industry is responding with a continuous stream of innovative products.
Report Highlights
-
The global market for industrial enzymes is estimated at $2 billion in 2004 and is expected to rise at an average annual growth rate (AAGR) of 3.3% to $2.4 billion in 2009.
-
Volume growth of industrial enzymes is between a 4% and 5% AAGR, and is accompanied by decreasing prices.
-
Growth of the animal feed enzyme sector is somewhat higher, at nearly a 4% AAGR, helped by increased use of phytase enzyme to fight phosphate pollution.
-
Technical enzymes for detergent and pulp and paper manufacturing, among others, are the largest segment with a 52% share. Growth will parallel the overall market.
Report Highlights
-
Total U.S. consumption of enzymes is estimated at $514 million in 2000.
-
Growing at an average annual rate (AAGR) of 4.1%, usage will reach $629.3 million by 2005.
-
Pulp and paper applications will show the most growth, at an AAGR of 6.5% through the period.
-
Detergent/cleaners are second, with 5% annually on average. Food and animal feed applications dominate the current market, accounting for just under half the total value.
Related Reports
Biorefinery Technologies: Global Markets
The global market for biorefinery technologies reached $342.8 billion in 2012. This market is expected to grow to $387.8 billion in 2013 and $700.7 billion in 2018 with a compound annual growth rate (CAGR) of 12.6% for the five-year period, 2013 to 2018.
Environmental Markets for Biotechnology
U.S. sales of environmental biotechnology products was valued at $241.2 million in 2012. This is expected to increase at a total compound annual growth rate (CAGR) of 7.9%, with 2013 sales of $261.9 million, rising to $382.3 million in 2018.
Kinase Inhibitors: Global Markets
The global kinase inhibitors market reached $28.1 billion in 2010 and nearly $29.1 billion in 2011. The market is expected to reach $40.2 billion by 2016, a compound annual growth rate (CAGR) of 6.7%.
Global Markets for Enzyme Inhibitors
The global market for enzyme inhibitors was valued at $104.4 billion in 2010 and reached nearly $104.6 billion in 2011. This market is expected to rise at a compound annual growth rate (CAGR) of 4% and reach nearly $127.4 billion by 2016.
Recent Reports
Bioprocess Optimization and Digital Bio-manufacturing: Global Markets
The global market for bioprocess optimization and digital biomanufacturing is expected to grow from $24.3 billion in 2024 and is projected to reach $39.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2024 to 2029.
Global DNA Sequencing: Research, Applied and Clinical Markets
The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.
Artificial Intelligence (AI) in Cancer
The global market for artificial intelligence (AI) in cancer is estimated to increase from $2.2 billion in 2024 to reach $6.3 billion by 2029, at a compound annual growth rate (CAGR) of 23.1% from 2024 through 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More